Stock listing
Zydus Lifesciences Limited
Selected listing: ZYDUSLIFE · NSE · INR · IN
Zydus Lifesciences Limited (NSE:ZYDUSLIFE), Health Technology. Latest release Oct 5, 2026: Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat…
- Ticker
- NSE:ZYDUSLIFE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NSE
- Currency
- INR
About Zydus Lifesciences Limited
The company operates in the pharmaceutical sector, focusing on the development and manufacturing of a wide range of healthcare products. Zydus Lifesciences is committed to innovation and improving patient outcomes through its diverse portfolio.
Latest news from Zydus Lifesciences Limited
Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
October 5, 2026
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 05, 2026, titled "Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.".
October 5, 2026
Zydus Lifesciences Limited Press Release Oct 02 2026
October 1, 2026
Zydus Lifesciences Limited Press Release Sep 30 2026
September 29, 2026
Zydus Lifesciences Limited Press Release Sep 29 2026
September 28, 2026
Research Zydus Lifesciences Limited
Zydus Lifesciences Limited company profile
View the public company page for Zydus Lifesciences Limited on 6ix.
Zydus Lifesciences Limited news
Read company news and market updates connected to Zydus Lifesciences Limited.
Zydus Lifesciences Limited investor events
Find investor webinars, events, and replay context for Zydus Lifesciences Limited.